FTC says AbbVie, Teva broke law in reaching AndroGel agreement | Business Information & News | Westlaw

FTC says AbbVie, Teva broke law in reaching AndroGel agreement | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, FTC says AbbVie, Teva broke law in reaching AndroGel agreement, Business Information & News
9/8/14 REUTERS 17:37:48
REUTERS
Copyright © 2014 Thomson Reuters
September 8, 2014
FTC says AbbVie, Teva broke law in reaching AndroGel agreement
Diane Bartz
WASHINGTON (Reuters) - Drug companies AbbVie Inc and Teva Pharmaceuticals Industries Ltd were sued by the U.S. Federal Trade Commission on Monday for allegedly illegally preventing generic production of AndroGel, used by men with low testosterone.
The...
---- Index References ----
Company: TEVA PHARMACEUTICAL INDUSTRIES LTD; ABBVIE INC
News Subject: (Patents (1PA79); Health & Wellness (1HE60); Legal (1LE33); Intellectual Property (1IN75))
Industry: (Men's Health (1ME04); Healthcare Practice Specialties (1HE49); Generic Drugs (1GE93); Pharmaceutical Patents (1PH40); Healthcare (1HE06); Pharmaceuticals & Biotechnology (1PH13); Pharmaceuticals (1PH33))
Language: EN
Other Indexing: (Edith Ramirez; Gary Cameron; Maureen Ohlhausen; Joshua Wright; Julie Brill; Terrell McSweeny)
Keywords: antitrust; health; products; ip (MCC:f); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR); (MCCL:OEC)
Word Count: 223
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.